Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Eden Innovations ( (AU:EDE) ) has issued an announcement.
Eden Innovations has begun larger-scale trials of its EdenCrete Pz7 concrete admixture in India in collaboration with the government’s Central Road Research Institute, targeting two widely used concrete grades (M60 and M40 PQC) employed in major infrastructure works. The testing aims to enhance flexural strength and abrasion resistance in concrete used for bridge overlays, ultra-thin white topping and new pavements, potentially helping address India’s recent issues with premature highway pavement failures and aligning with the government’s shift toward higher-quality, more sustainable construction methods; if successful, the trials could significantly boost Eden’s Indian sales and open a sizeable market, including anticipated projects by the Maharashtra State Infrastructure Development Corporation.
The most recent analyst rating on (AU:EDE) stock is a Hold with a A$0.07 price target. To see the full list of analyst forecasts on Eden Innovations stock, see the AU:EDE Stock Forecast page.
More about Eden Innovations
Eden Innovations Ltd is an Australian technology company focused on advanced concrete admixtures, notably its EdenCrete range, which are designed to improve the performance and durability of concrete used in infrastructure projects. Through its wholly owned subsidiary Eden Innovations India Pvt Ltd, the company targets the large and growing Indian infrastructure market, particularly highway, road and pavement construction.
YTD Price Performance: 42.00%
Average Trading Volume: 1,311,432
Technical Sentiment Signal: Sell
Current Market Cap: A$39.09M
For detailed information about EDE stock, go to TipRanks’ Stock Analysis page.